TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from TOT BIOPHARM International Co. Ltd. ( (HK:1875) ).
TOT BIOPHARM International Co. Ltd. has announced a new composition for its board of directors and committees, effective from March 12, 2025. The board will include a mix of executive, non-executive, and independent non-executive directors, with specific roles assigned across four key committees: Audit and Connected Transactions Review, Remuneration, Nomination, and Strategy and ESG. This restructuring is likely aimed at strengthening governance and strategic oversight, potentially impacting the company’s operational focus and stakeholder engagement.
More about TOT BIOPHARM International Co. Ltd.
YTD Price Performance: 17.32%
Average Trading Volume: 107,991
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$1.62B
For detailed information about 1875 stock, go to TipRanks’ Stock Analysis page.